Journal
LEUKEMIA
Volume 23, Issue 3, Pages 435-441Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/leu.2008.336
Keywords
multiple myeloma; osteoclast; osteoblast; bone disease
Categories
Funding
- Multiple Myeloma Research Foundation
- Department of Veteran's Affairs
Ask authors/readers for more resources
Bone disease in multiple myeloma (MM) is characterized by lytic bone lesions, which can cause severe bone pain, pathologic fractures and hypercalcemia. However, the lytic bone disease in MM differs from that in other cancer patients who have lytic bone metastases. Although increased osteoclastic bone destruction is involved in MM and other tumors involving bone, in contrast to other tumors, once the MM tumor burden exceeds 50% in a local area, osteoblast activity is either suppressed or absent. 1 The basis for this severe imbalance between increased osteoclastic bone resorption and decreased bone formation has been a topic of intensive investigation over the last several years and will be reviewed in this article.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available